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1. Introduction
The recent field releases of genetically modified mosquitoes in inter alia The Cayman Islands,
Malaysia and Brazil have been the source of intense debate in the specialized press [1, 2] as
well as in the non-specialized mass media. For the first time in history (to our knowledge),
transgenic Aedes aegypti were released in the Cayman Islands in 2010 by a private company,
Oxitec, in collaboration with the local Mosquito Research and Control Unit (MRCU) [3]. The
releases were followed by other releases in Malaysia in 2010/11 and then in Brazil in 2011 [4].
While the releases in Malaysia and Brazil were publicised beforehand, the releases in The
Cayman Islands were only announced publicly one year after the fact [1, 5]. This lack of
transparency, not to say the secrecy, in the way the first trial was conducted is without much
doubt the major reason for the controversy that emerged. Brushing aside years of discussion
in the scientific world and a shared recognition of the importance to consider ethical, legal and
social issues this first trial could be read as a fait-accompli: the cage of transgenic mosquitoes
has now been opened [6]. Oxitec faced harsh criticism for these releases, both within the
scientific community, as well as from non-governmental organisations, such as GeneWatch
that accused the company of acting like “a last bastion of colonialism”. A vector-borne diseases
method for control has rarely been the subject of such discussion not even concerning its
potential efficacy at reducing the burden associated with a vector-borne disease.
Focusing on malaria control, this chapter reviews the major technological milestones associ‐
ated with this technique from its roots to its most recent development. Key-points in the
understanding of mosquito ecology are going to be presented, as well as their use in models
whose major aim is to determine the validity of the transgenic approach and to help designing
successful strategies for disease control.
© 2013 Boëte and Beisel; licensee InTech. This is an open access article distributed under the terms of the
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Furthermore, the ethical and social points related to both field trials and wide-scale releases
aiming at modifying mosquito populations (and thus controlling vector-borne diseases) are
going to be discussed as well as the question of public engagement and the role scientists might
play in fostering debate and public deliberation. While large part of the laboratory research is
done in the Global North, most of the vector-borne diseases are endemic in the Global South.
We suggest that the geopolitics related to the genetically modified (GM) mosquitoes as well
as the specificity of Southern contexts needs to be considered when discussing the application
of this technology.
2. Why acting on the vector population: How efficient are transgenic
methods for malaria control?
When discussing the epidemiology of malaria the gold standard is the description of the R0 [7-9].
Focusing on the vector compartment suggests that the spread of malaria can be curved either by
reducing the mosquito population or by decreasing their vectorial capacity. In other words, one
either aims to decrease the number of mosquitoes or to make them less efficient in transmit‐
ting the parasites. These two strategies can both be addressed by vector control including through
a transgenic approach: population reduction or population replacement.  However, when
looking closely at R0 one can notice that the parameters that are affected by those strategies are
not the most likely ones to curve transmission efficiently. The mortality of mosquitoes (µ) and
their biting rate (a) are indeed affecting R0 in an exponential and in a quadratic manner respec‐
tively. In this respect, they are the parameters whose modifications affect R0 and consequently
the human prevalence mostly (see Box 1). This means that modifying a linear parameter is less
likely to lead to a drastic change in malaria epidemiology. For example halving the vector
population density (m) is going to reduce R0 by two but because of the non-linear relationship
between R0 and the human prevalence (y) the decrease of the latter one is not going to be affected
in such a manner especially in a context of high transmission.
3. Technology: What has lead to GM mosquitoes for malaria control?
The roots of the technology can be traced back to the early 80’s/90’s when the knowledge gained
in genetics in Drosophila research sparked the development of new tools in the fight of vector-
borne diseases. The plan was straightforward with three milestones to be achieved in a decade:
i) the stable transformation of Anopheles mosquitoes by 2000 ii) the engineering of a mosquito
unable to carry malaria parasites by 2005 and iii) the development of controlled experiments
to understand how to drive this genotype of interest into wild populations by 2010 [10].
Regarding malaria most recent research has concentrated on the development of an Anophe‐
les strain that has the ability to interrupt transmission through the synthesis and production
of molecules able to block the development of the parasite. A few years ago, the SM1 peptide
was shown to reduce malaria oocysts number by about 80% [11]. More recently, it was
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synthesised from a transgenic entomopathogenic fungi [12], this later one is by-itself (in its
natural version) already considered as a potentially interesting method to develop [13-15].
Other potential solutions currently developed rely on single-chain antibodies [16-18]. Using
the φC31 integration system for the first time in An. stephensi it is now possible to insert the
transgene of interest in a permanent manner at chromosomal ‘docking’ site using site-specific
recombination and to have a tissue- and sex-specific expression. The authors have then shown
that the prevalence and number of oocysts decreased when the transgenic mosquitoes were
Box 1. The Ross-MacDonald model permits to describe R0 which is the number of secondary case arising from a single
one in an otherwise uninfected population (Macdonald 1957; Koella, 1991). It permits to determine the relative im‐
portance of the different parameters implicated in the transmission of malaria (equation 1). From the R0 value, a sim‐
ple expression permits to determine the prevalence in the human population (equation 2). As seen on the graph
above, only a large decrease in the intensity of transmission (estimated by R0) can affect significantly the human prev‐
alence (y).
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challenged with Plasmodium falciparum [17]. If technology has been able to determine how the
insertion of a transgene can be made to change a vector to a quasi non-vector, the next question
to answer concerns the spread of this construction in natural populations of mosquitoes.
4. Mosquito ecology: First hurdle at the door of the Lab
When the ecological and evolutionary issues related to the potential use and impact of
Plasmodium-resistant transgenic mosquitoes started to be discussed about a decade ago [19,
20], most studies aimed at providing information on the fitness of genetically-modified
mosquitoes were based on the use of natural mosquito immune responses as a model system.
This was mainly driven by the fact that using the natural immune system of mosquitoes in a
transgenic approach was considered of some potential interest [21], and also because the only
fully effective system against malaria parasite was the melanization response (also known as
melanotic encapsulation) in selected lines of mosquitoes [22]. The mechanism leading to the
death of the parasite because of melanization remains unclear. It seems that death can occur
because of starvation (by isolation from the hemolymph) as well as because of the cytotoxic
function of melanin [21, 23]. The melanization response was then considered as a model of
what could happen with an artificial peptide mimicking an immune response and thus aiming
at reducing the number of parasites in the mosquito.
Before considering the cost associated with resistance that could impair the spread of resistance
in mosquito populations, it is important to notice that the sole insertion of an exogenous gene
(not even conferring any anti-parasitic advantage) leads to a drastic decrease in Anopheles
stephensi fitness [24]. However, recent work with site-specific insertion seems to bring a less
negative outcome in term of fitness [18]. This even seems to be the case when all different
groups including the control group (called wild) derive from a lab colony and the fitness
reduction due to the colonisation process is probably significant. Concerning the cost of
resistance, mosquitoes are no exception and reduced fitness associated with the absence of
parasite can be observed. Thus, several studies have measured the associated cost in Anopheles
stephensi carrying a transgene conferring resistance again the rodent malaria parasite P.
gallinaceum. Regardless if resistance was provided by the expression of SM1 (termed for
salivary gland- and midgut binding peptide 1) [25] or the phospholipase A2 gene (PLA2) [26],
a fitness cost was associated with it. Even in conditions where harbouring an allele conferred
an advantage i.e. when mosquitoes were fed on Plasmodium-infected blood, the SM1 transgene
could not reach fixation revealing that the benefit of resistance was counterbalanced by the
cost of resistance in the transgenic homozygotes [27]. In any case the construction needs to
follow a couple of requirements for the promoter and the gene of interest for the method to
have some chances of success [28]. The gene of interest needs to express in a temporal manner
i.e. after a blood-meal is taken, but also only in the tissues where it could efficiently impact the
parasite life cycle, such as the midgut epithelium and the salivary glands.
Recent work on GM mosquitoes have also been done with Aedes that are not resistant towards
a pathogen but that are carrying a gene that makes nearly all their offspring non-viable in a
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natural environment [29-31]. To date such a strategy has not been developed for the Anophe‐
les genus.
For the strategy considering the replacement of malaria vector by their modified non-vector
version, this question of a cost associated with resistance leads necessarily to the idea of the
need to use a driving system in order to favour the spread of resistance in natural populations
of mosquitoes.
5. Driving an allele of interest in natural populations of mosquitoes
The idea of using a gene drive to affect the epidemiology of vector-borne diseases is not a recent
idea as the use of chromosomal translocation to reduce mosquito populations was already
proposed in 1940 by Serebrovskii [32]. It was revived later with the idea to use those translo‐
cations to drive alleles conferring refractoriness in mosquito populations [33].
Thus the spread of refractoriness in mosquito populations could be facilitated if the allele,
conferring resistance but also associated with a cost, was linked with an element whose spread
is not Mendelian. One of the techniques for which various models provide information is the
use of transposable elements. A tandem made of a transposon and an allele of interest can
spread easily and fixation can be reached [34, 35], even if the cost of resistance is particularly
high [36].
Using intracellular bacteria associated with cytoplasmic incompatibility, such as Wolbachia, is
also an idea that has been explored. Modifying them so that they could harbour the allele of
interest would permit, at least in theory, to favour the spread of the allele of interest [37, 38].
There is no natural infection of Anopheles by Wolbachia but work is in progress trialling
infections of Anopheles gambiae cells by Wolbachia pipientis (strains wRi and wAlbB) in the lab
[39]. However, up to now no such sustainable transformation has been done [40].
Other constructions that would favour the spread of resistance have also been considered [41,
42]. Among them the use of HEG (Homing Endonuclease Genes) has been the centre of a lot
of attention in the last years [43-45]. Apart from those systems another approach relies on the
use of pairs of unlinked lethal genes. In this case, each gene is associated with the repressor of
the lethality of the other one and this system is called engineered underdominance [46]. With
respect to those methods a number of recent papers have been focusing on theoretical work
aiming at spreading an allele conferring resistance as well as containing it. If the aim of a GM
approach is to favour the spread of an allele conferring resistance it is also important to consider
that self-limitation could be a real advantage to avoid the establishment of the transgene in
non-target populations. Such an approach has been studied in theoretical analysis with the
Inverse Medea gene drive system [47] and with the Semele one [48].
If the speed at which the construction of interest can spread in mosquito populations is a major
issue, authors have also shown that in the case of the use of transposable elements one of the
problems is the stability of the system with the probability of disruption [49].
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However, if the spread of an allele conferring resistance is a target that can be reached, the real
aim should be a strong decrease in the prevalence of the disease or even its elimination. Two
models merging population genetics and epidemiology have pointed out the major impor‐
tance of the efficacy of resistance [36, 50]. They have shown that a significant reduction in
malaria prevalence can only be obtained if the efficacy is close to 1 especially when a release
of resistant mosquitoes is done in high transmission areas.
If recent work claims that the engineered-mosquito do not suffer too much from carrying a
resistant allele [17], this remain only valid under lab conditions where environmental condi‐
tions remain fairly stable and usually favourable. It is interesting to note that the survival of
the mosquitoes in Isaacs et al. study reaches about 35 to 40 days which is probably far more
that what happens under natural conditions.
As shown with natural immune responses, environmental conditions experienced at the larval
or at the adult stage can greatly affect the host-parasite interactions and thus the outcome of
an infection [51]. A reduction of 75% on food availability at the larval stage in lines selected
for refractoriness [22] leads to a decrease in the proportion of the mosquitoes able to melanize
half of the surface of a foreign body (a Sephadex bead) of more than 50% of it [52]. Even more
worryingly, a recent paper [53] revealed the complex effects of temperature on both the cellular
and humoral immune responses on the malaria vector Anopheles stephensi. What is highly
interesting in this study is that not only temperature can affect immune responses but also that
different immune responses are affected in different manners by temperature. The authors
have studied the melanization response, the phagocytosis (a cellular immune response that
lead to the destruction of small organisms or apoptotic cells) and the defensin (an antimicrobial
peptide) expression. The three of them are higher at 18°C while the expression of Nitric Oxide
Synthase (active against a large number of pathogens [54]) peaks at 30°C and the one of
cecropin (an antimicrobial peptide) seems to be temperature-independent. Concerning
melanization it is important to note that if the melanization rate is higher at 18°C, the percent‐
age of melanised beads -introduced inside the mosquito to measure its immunocompetence-
(at least partly) was higher when the temperature increased (fig. 1).
This result highlights the difficulties to define what is an optimal temperature for the melani‐
zation response especially as it is also involved in developmental processes. The complexity
of the immune function appears also with cecropin expression that despite being independent
from temperature was affected by the administration of an injury or the injection of heat-killed
E. coli. Other works have also revealed that the immune function is affected in a complex
manner by a variety of environmental parameters such as the density of conspecifics or the
quality of food resources [55]. Apart from showing the need to better understand the impact
of the complex interactions between temperature and other variables on the vector compe‐
tence, this work also highlights the crucial importance to take them into account when
determining the potential outcome of the interactions between the natural immune function,
the allele conferring resistance in a GM mosquito and finally the resulting vectorial competence
under a large variety of ecological conditions.
What appears to be clear is that the expression of genes involved in the anti-parasitic response
are not only influenced by the sole host-parasite interactions but that the environment is a
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crucial factor be it the abiotic conditions, such as temperature and its daily variations, or biotic
factors, such as parasites encountered at the larval or adult stage [56, 57].
On the side of the parasite it would be naïve not to consider an evolutionary response in the
face of selective pressure represented by any (natural or artificial) resistance. The quick
selection of resistance against artemisinin in South-East Asia in the last years [58] and the
evidence of its genetic basis [59] suggests that it is reasonable to envision the selection of
parasite strains able to overcome any engineered resistance mechanism. Using transgenic
Plasmodium-resistant mosquitoes can be considered equivalent to artificially increasing the
investment of the mosquito in an immune response. Referring to some theoretical work [60]
this is assumed to be followed by an increase in the parasite investment to avoid resistance. In
the long term this would lead to a decrease in the effectiveness of the programme aiming at
decreasing malaria prevalence or the need to ‘play evolution’ by monitoring the parasite
population and releasing transgenic mosquitoes for which resistance could be modified as in
an arm race with parasite evasion.
What is then important is to determine the longer-term of such a strategy regarding parasite
virulence. Some answers have already been provided by theoretical work concerning the
impact on parasite virulence to humans and mosquitoes in the case of dengue [61]. The authors
examined four distinct situations: blocking transmission, decreasing mosquito biting rate,
increasing mosquito background mortality or increasing the mortality due to infection; if all
of them are associated with a benefit in terms of disease incidence, only the ones affecting
mosquito mortality seem to pose the smallest risk in term of virulence to humans. It is
important to note the scarcity of studies aiming at providing empirical data on this topic even
Figure 1. Influence of the temperature on the melanization response of Sephadex beads in the malaria vector Anoph‐
eles stephensi. The melanization of beads was measured 24h after the injection. The proportion of completely melan‐
ized beads was the highest at 18°C whereas the higher proportion of beads being at least partially melanized occurs
at higher temperatures (modified after Murdock et al. 2012)[53].
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if experimental evolution with mosquitoes and parasite can provide interesting results in a
reasonable number of generations [62]. This lack of data not only concerns dengue but also
malaria as has already been discussed in a paper on possible outcomes of the use of transgenic
Plasmodium-resistant mosquitoes [63].
6. Vector control: To be or not to be transgenic-based
As mentioned earlier one of the major points to consider with transgenic mosquitoes used for
malaria control are the ethical and societal issues and public acceptance of this high-tech
method. Even though the importance of societal acceptance of GM mosquitoes has been
recognised for a decade [64], studies on acceptability remain scarce. One first study conducted
in Mali mapped out several crucial aspects of potential acceptance or rejection of GM mos‐
quitoes [65]. While Marshall reports that his interviewees were generally “pragmatic” about
the technology, acceptance was dependent on several conditions.
If people were supportive of a release of transgenic mosquitoes for malaria control, they first
wanted to see evidence of safety for human health and the environment prior to releases. In
addition, proof of efficacy of the technology in reducing malaria prevalence was requested.
Lastly people declared that they would prefer the trial to be done outside of their village and
when comparing GM crops and GM mosquitoes, people were more sceptical of the latter. Even
if this not a rejection of the idea of using a GM technology for health purpose, it is important
to note that a population, even if at risk of contracting malaria, remains cautious about the idea
of using such a technology. This should remind us how, in the 70’s, a decade-long programme
conducted by the WHO in India utilising the sterile insect technique (SIT) ended in a chaotic
way after the publication of inaccurate information in the Indian press [66].
Secondly, the question of regulation has recently been highlighted as crucial [5, 67]. Because
the social and environmental implications of GM mosquitoes are significant and potentially
irreversible, and as the regulatory attention that GMOs have received in Europe suggests
broad-based trials and releases require robust legislation and international agreements. These
regulations are still under development, and it is important to note that at the time of the first
releases in The Cayman Islands international guidance on open field releases of GM mosqui‐
toes was still in preparation [67, 68]. While the existing Cartagena Protocol on Biosafety is
considered to be applicable to GM crops, it is in need of specific amendments in order to work
for GM mosquitoes [69].
Furthermore, in terms of regulation one has to distinguish between two different types of GM
mosquitoes. While regulation and tracking might be possible for genetically sterilised mos‐
quitoes as they are self-limiting in their spread, tracking and containment of GM mosquitoes
with self-spreading genetics, i.e. fertile mosquitoes that block disease transmission, is consid‐
ered almost impossible, or at the very least extremely difficult [70, 71]. This distinguishes GM
mosquitoes from earlier GM technologies, such as for the modification of crops. GM and non-
GM crops can be separated from each other and marked by labels on GM products, it can thus
be seen as a technology of choice. However, the accuracy of this argument is only limited. As
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for instance Lezaun has shown, bees have proven to be effective agents of cross-pollination
between GM and non-GM crops, thus subverting regulations that aim to keep GM and non-
GM crops separate [72]. GM insects, however, are markedly different. The elusiveness of
mosquitoes will likely be a major impediment to tracking, containment and comprehensive
regulation, as for instance the spread of Aedes albopictus and herewith the increased risk of
arboviral transmission in new locations across the world has shown, mosquitoes are hard to
contain. This renders GM mosquitoes as a no-choice technology – once released, GM mosqui‐
toes will stay in our environments.
A second major issue in terms of the social and ethical implications of GM mosquitoes is the
question by whom and how they are produced and implemented. GM modification of insects
is an expensive high-tech intervention and research so far has mainly been located in resource
rich laboratories in the Global North, rather than in disease-endemic developing countries [73].
This enrols the technology thoroughly into discussions about technology transfer and devel‐
opment initiatives from North to South, and sits uncomfortably with the West’s history in
colonial exploitation and tropical medicine. Aside from this imbalance in bio-capital and
agenda setting, GM mosquitoes are as much a product of the biotech industry as they are tools
for public or global health. Are GM mosquitoes currently seen as a public good or a commercial
product? While most of the research and development of GM mosquitoes has so far been
funded by public institutions –both national research foundations -such as the US National
Science Foundation- and philanthropic organisations -such as the Bill and Melinda Gates
Foundation and the Wellcome Trust, the mosquitoes that have been released were part of a
commercial project. The emerging GM mosquito industry has caught the interest of private
biotech firms. The first company to produce and market GM mosquitoes is Oxford Insect
Technologies (Oxitec), founded by a group of entomologists as a spin-off company of Oxford
University. The company is a for-profit-enterprise, so far has mainly been funded by public
entities and venture capitalists, and is one of the main drivers of high-end developments in
the field. As discussed in the introduction, Oxitec was the first to release sterile GM mosquitoes
into the wild in the field trials in The Cayman Islands. A fundamental issue that is raised
through the dominance of Oxitec in the field is the tension between GM mosquitoes as a public
health tool and a commercial product [74-76]. While GM mosquitoes in malaria control would
be used as a tool of disease control and to foster public health, companies like Oxitec follow
different aims – they have to become profitable and eventually make profits with their GM
entities. This tension brings another social issue of GM mosquitoes to the forefront, namely
the question of how one conducts field trials with GM mosquitoes in an ethical way?
As we alluded to in the introduction, the first releases in The Cayman Islands were conducted
in a rather secretive fashion. Oxitec only published the news about the release with a one-year
delay [1], leading to accusations that the releases were deliberately done in secret [75, 76].
Oxitec stated the trials were prepared and conducted in close cooperation with local Mosquito
Control and Research Unit, had conformed to the British Overseas Territory’s biosafety rules,
and that information had been sent to local newspapers preceding the trials. However, many
locals claimed they were not informed and no risk assessment documents were made available
to the public on the internet. The only risk assessment document that can be found was
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published by the UK parliament in 2011, over one year after the releases started [5]. The
Cayman Island releases have triggered fears for entomologists working on GM mosquitoes
that such secretive trials might lead to a public backlash and undermine their own extensive
efforts at public engagement, some scientists for instance claimed they have spent years
preparing a study site through “extensive dialogues with citizen groups, regulators, academics
and farmers”[1].
GeneWatch argued that Oxitec purposefully bypassed existing international GM regulations
(developed mainly for GM crops), because Cayman Islands does not have biosafety laws and
is not a signatory to the Cartagena Protocol on Biosafety or the Aarhus Convention (even
though since the UK is a signatory to the protocol, Oxitec had a duty to report the export of
GM eggs to UK government). As a result GeneWatch reads Oxitec’s actions as colonialist
tactics: “the British scientific establishment is acting like the last bastion of colonialism, using
an Overseas Territory as a private lab” [76].
All in all, this raises the question what ethically and socially responsible research on GM
mosquitoes means? Here, the ability of researchers and stakeholders to communicate with
each other is key for meaningful public engagement. In this respect, a recent survey has focused
on the willingness of scientists to have interactions with a non-scientific audience [77]. One of
the main findings of the survey indicates that more than 90% of scientists working on GM
mosquitoes are agreeable to interactions with the public on their research. However, commu‐
nication might not be enough and real discussion might not be easy between researchers and
a non-scientific audience. This has been underlined by the reluctance of a fraction of the
research community to have their research project evaluated by a non-scientific public [77].
Thus, while a significant proportion of researchers are ready to interact with a non-scientific
audience, they seem to be less likely to accept an evaluation and a prior-agreement of a research
proposal by the general public, interestingly especially researchers from the Global North are
hesitant. On the other hand, many scientists in malarious countries do welcome exchanges
with publics and are more willing to negotiate their research project with members of the
disease-endemic communities.
In summary, the GM mosquito technology in malaria control raises a set of challenging
questions. Challenges from a biological and ecological perspective are interlinked with
questions about democratic decision-making, local acceptance and international regulation of
these emerging entities. Such a potentially controversial technology cannot afford to skip these
debates and time is ripe to focus on the ethical and sociological aspects governing the potential
use of GM mosquitoes. Furthermore, it is crucial that the development of transgenic methods
does not lead to a decrease in funding of classical, accepted and efficient vector control methods
– indeed, they should be favoured and enhanced to continue curbing the malaria burden today.
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